Mitochondrial homeostasis in cancer: Functions and targeted therapies

Area of Science:

• Oncology
• Mitochondrial Biology
• Cancer Metabolism

Background:

• Mitochondrial homeostasis is frequently dysregulated in tumor cells, supporting tumorigenesis and progression.
• Tumor cell mitochondria undergo mutations, proliferation, and fragmentation to meet increased metabolic demands.
• This disruption impacts tumor cell proliferation, invasion, metastasis, energy metabolism, and redox balance.

Purpose of the Study:

• To review recent advancements in understanding mitochondrial homeostatic dysregulation in cancer.
• To discuss the therapeutic potential of targeting oncogenic mitochondria in tumor treatment.

Main Methods:

• Literature review of current research on mitochondrial dysfunction in cancer.
• Analysis of the role of mitochondrial homeostasis in oncogenesis.
• Exploration of mitochondria-targeted pharmaceuticals in preclinical and clinical studies.

Main Results:

• Significant alterations in mitochondrial structure and function are characteristic of tumor cells.
• Dysregulated mitochondrial homeostasis is a key driver of cancer progression and metastasis.
• Mitochondria-targeted therapies demonstrate potential for novel cancer treatment strategies.

Conclusions:

• Targeting oncogenic mitochondria represents a promising therapeutic avenue for cancer management.
• Further research into mitochondria-targeted pharmaceuticals could lead to breakthroughs in tumor therapy.